COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID [preprint]
Butzin-Dozier, Zachary ; Ji, Yunwen ; Wang, Lin-Chiun ; Anzalone, A Jerrod ; Coyle, Jeremy ; Phillips, Rachael V ; Patel, Rena C ; Sun, Jing ; Hurwitz, Eric ; Deshpande, Sarang ... show 5 more
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Subject Area
Files
Embargo Expiration Date
Link to Full Text
Abstract
Objectives: Long COVID is a debilitating condition that impacts millions of Americans, but patients and clinicians have little information on how to prevent this disorder. Vaccination is a vital tool in preventing acute COVID-19 and may confer additional protection against Long COVID. There is limited evidence regarding the optimal timing of COVID-19 vaccination (i.e., vaccination schedule) to minimize the risk of Long COVID.
Methods: We applied Longitudinal Targeted Maximum Likelihood Estimation to electronic health record (EHR) data from a retrospective cohort of patients vaccinated against COVID-19 between December 2021 and September 2022. We evaluated the association between binary COVID-19 vaccination status (two or more doses vs. zero doses) and 12-month Long COVID risk among patients diagnosed with acute COVID-19 between December 2021 and September 2022. In addition, we compared the 12-month cumulative risk of Long COVID (ICD-10 code U09.9) among patients diagnosed with acute COVID-19 one to three months after vaccination, three to five months after vaccination, or five to seven months after vaccination while adjusting for relevant high-dimensional baseline and time-dependent covariates.
Results: We analyzed EHR data from a retrospective cohort of 1,558,018 patients. In our binary cohort (n = 519,980), we found that vaccinated patients had a lower risk of Long COVID than unvaccinated patients (adjusted marginal risk ratio 0.84 (0.81, 0.88)). In our longitudinal cohort (n = 1,085,291), we did not find a significant difference in Long COVID risk comparing patients who were diagnosed with acute COVID-19 one to three months after vaccination versus patients who were diagnosed with COVID-19 three to five months (adjusted marginal risk ratio 0.93 (95% CI 0.62, 1.41) or 5 to 7 months (adjusted marginal risk ratio 1.06 (95% CI 0.72, 1.56)) after vaccination.
Conclusions: We found that COVID-19 vaccination before SARS-CoV-2 infection was protective against Long COVID, and we did not find that this protection significantly waned within 7 months after vaccination. These findings suggest that COVID-19 vaccination protects against Long COVID.
Source
Butzin-Dozier Z, Ji Y, Wang LC, Anzalone AJ, Coyle J, Phillips RV, Patel RC, Sun J, Hurwitz E, Deshpande S, Shi JS, Mertens A, van der Laan MJ, Colford JM Jr, Hubbard AE. COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID. medRxiv [Preprint]. 2025 Apr 23:2025.04.22.25326224. doi: 10.1101/2025.04.22.25326224. PMID: 40313290; PMCID: PMC12045423.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
Permanent Link to this Item
PubMed ID
Other Identifiers
Notes
This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.